Everything you need to know about getting a second opinion before heart surgery.

Studies consistently show that 30-40% of cardiac surgery second opinions result in a change in the treatment recommendation. This is not because the first physician was wrong — it reflects the genuine complexity of cardiac surgical decisions and the reality that reasonable experts can disagree on the best approach for a given patient.
The American Heart Association and the American College of Cardiology both support the practice of seeking second opinions for complex cardiac decisions. In fact, the Heart Team approach — which is essentially an institutionalized second opinion — is a Class I (strongest) recommendation in the ACC/AHA guidelines for valvular heart disease.
Consider the decision between TAVR and surgical aortic valve replacement for a 72-year-old patient with severe aortic stenosis. A cardiac surgeon may favor surgical replacement based on long-term durability data. An interventional cardiologist may favor TAVR based on shorter recovery and comparable mid-term outcomes. Both perspectives are valid — and both are essential for informed decision-making.
You should consider a second opinion before any elective cardiac surgery. Specific scenarios where a second opinion is particularly valuable include:
A comprehensive cardiac surgery second opinion includes several components:
1. Complete medical record review. All of your records — including operative reports, catheterization films, echocardiograms, CT scans, and clinical notes — are reviewed independently by the consulting team.
2. Independent imaging interpretation. Your imaging studies are re-read by the second opinion team, not simply accepted at face value. Discrepancies between interpretations are common and clinically significant.
3. Quantified risk assessment. Your surgical risk is calculated using validated models including the STS Predicted Risk of Mortality (PROM), EuroSCORE II, and procedure-specific models.
4. Guideline-based evaluation. Your case is evaluated against current ACC/AHA and ESC guidelines, with specific attention to evidence class and level of recommendation.
5. Treatment alternatives analysis. The second opinion should evaluate not just the proposed treatment, but all reasonable alternatives — including medical management.
Historically, getting a cardiac surgery second opinion required traveling to another medical center — often across the country — for an in-person evaluation. This created barriers including cost, time, physical ability (many cardiac patients have limited mobility), and the stress of travel.
Virtual second opinions have eliminated these barriers. A comprehensive virtual review uses the same clinical data as an in-person evaluation: medical records, imaging studies, lab results, and clinical notes. The key distinction is that a virtual second opinion does not include a physical examination — however, in cardiac surgery, the critical decision-making information comes from imaging and risk assessment, not the physical exam.
WhiteGloveMD delivers virtual second opinions with a 48-hour turnaround, using a dual-physician Heart Team model augmented by AI-powered clinical decision support. Every case is reviewed independently by a cardiac surgeon and a cardiologist, ensuring both surgical and interventional perspectives are represented.
The Heart Team concept emerged from landmark clinical trials like SYNTAX, which demonstrated that treatment decisions for complex coronary artery disease benefit from multidisciplinary discussion. The 2020 ACC/AHA Guidelines for Valvular Heart Disease give a Class I recommendation for Heart Team evaluation of patients with severe aortic stenosis being considered for valve replacement.
A Heart Team typically includes:
WhiteGloveMD's Heart Team model ensures that every patient receives this level of multidisciplinary evaluation — not just patients at major academic medical centers.
Risk scoring is fundamental to cardiac surgical decision-making. The three most widely used models are:
STS PROM (Society of Thoracic Surgeons Predicted Risk of Mortality): The US standard, calibrated against 7+ million cases in the STS National Database. Uses approximately 40 patient variables. An STS PROM under 3% is low risk, 3-8% is intermediate, and above 8% is high risk.
EuroSCORE II: The European standard, using 18 variables from European surgical databases. Widely used alongside STS for cross-validation.
AATS Risk Calculator: Developed by the American Association for Thoracic Surgery, uses 75+ variables for detailed procedure-specific predictions including mortality, stroke, renal failure, prolonged ventilation, and wound infection.
WhiteGloveMD calculates all three risk scores for every patient, providing a cross-validated risk assessment that identifies discrepancies between models and gives patients and referring physicians the most complete risk picture available.
Surgeon selection is one of the most impactful variables in cardiac surgery outcomes — yet it is rarely discussed openly with patients. Key data points include:
Volume-outcome relationship: Surgeons who perform more of a specific procedure generally achieve better outcomes. For CABG, surgeons performing fewer than 50 cases per year have measurably higher mortality. For mitral valve repair, surgeon repair rates range from below 50% to above 99%.
STS star ratings: The STS publishes 1-star, 2-star, and 3-star ratings for hospitals based on risk-adjusted cardiac surgery outcomes. These ratings are publicly available and should be reviewed before choosing a hospital.
Specialization matters: A surgeon who specializes in aortic root surgery will generally achieve better outcomes for Bentall procedures than a general cardiac surgeon who performs one or two per year. For rare or complex procedures, referral to a specialist is strongly recommended.
Our Hospital Quality Lookup tool provides searchable data on cardiac surgery programs across the country.
Most insurance plans cover in-network second opinions, and many explicitly encourage them for major procedures. Some plans require a second opinion before authorizing elective surgery. Even when a second opinion is out-of-pocket, the cost is a fraction of the surgery itself — and the information gained can prevent unnecessary procedures, identify better approaches, or confirm that the current plan is optimal.
WhiteGloveMD second opinions start at $495 during our inaugural period, with packages ranging up to $5,995 for comprehensive concierge service through discharge. Visit our pricing page for details.
HSA and FSA funds can typically be used for second opinion services. We provide detailed receipts and documentation for insurance reimbursement or tax-advantaged account claims.
No. Experienced surgeons expect and welcome second opinions, particularly for complex cases. A surgeon who discourages a second opinion is a red flag. The best surgeons are confident that their recommendation will be validated by independent review.
WhiteGloveMD delivers comprehensive second opinions within 48 hours of receiving complete medical records. Traditional in-person second opinions may take 2-4 weeks to schedule and complete.
Disagreement is not uncommon — it occurs in 30-40% of cases. When opinions differ, patients should discuss the discrepancies with both teams and consider a Heart Team conference. The disagreement itself is valuable information.
No. Virtual second opinions provide the same clinical depth using your existing medical records and imaging. WhiteGloveMD reviews are entirely remote with no travel required.
Ideally: cardiac catheterization films, echocardiogram reports and images, CT scans if available, operative reports from prior surgeries, and relevant clinical notes. WhiteGloveMD guides you through the record collection process.
Many insurance plans cover second opinions. Some require them before authorizing surgery. WhiteGloveMD provides documentation for insurance reimbursement. HSA/FSA funds are typically eligible.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 48 hours. Starting at $495 during our inaugural period.